. 2021 Jul 7;148(13):1545–1553. doi: 10.1017/S0031182021001128

Table 1.

Effect of treatment during the enteral stage of the infection¹ on the host intestinal parasite burden and T. spiralis female fecundity

	CBi/L		CBi+
	Males	Females	Males	Females
Treatment	Variable: nAP²
Control	6.5 (2–17)^a	2.0 (0–5)^a	13.5 (9–19)^a	22.0 (10–27)^a
ABZ	7.0 (3–8)^a	1.5 (0–3)^a	13.5 (10–17)^a	8.0 (3–17)^a
S4A	6.5 (1–8)^a	2.0 (0–10)^a	19.5 (13–24)^a	17.0 (14–20)^a
S10A	7.0 (3–14)^a	0 (0–3)^a	15.0 (5–23)^a	21.0 (20–23)^a
	Variable: Ff³
Control	29 ± 15.2	34⁴	50 ± 25.0	46 ± 16.6
ABZ	–	–	–	–
S4A	–	–	–	–
S10A	–	–	–	–

nAP, total number of intestinal adult parasites; Ff, T. spiralis female fecundity.

nAP differences among treatments within genotype and sex were evaluated with the nonparametric Kruskal–Wallis test followed by Dunn's test for between-groups comparison (nAP).

For each column, differences between groups not sharing the same superscript are significant at the 0.05 level.

Mice were treated on days 5, 6 and 7 p-i and sacrificed two days after the administration of the last dose (9 days p-i).

Median (range).

Mean ± s.e.m.

⁴

Only one female recovered.